Daiichi Sankyo Company, Limited

Ticker

4568.T

ISIN

JP3475350009

Price

JPY 5,426.00

Change Today

-70.00 / -1.274 %

Price 1 year ago

4,384.01 / 23.768 %

Market Capitalization

6,948,152,410,112.00

52 Week Low

3,557.41

52 Week High

5,531.00

200 Day Moving Average

4,386.07

50-day Moving Average

4,924.34


Price evolution

Yearly Returns


Peers


Peers

Company information

Summary

Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment. It also provides olmesartan, an antihypertensive agent; levofloxacin, an antibacterial agent; pravastatin for hypercholesterolemia treatment; and loxoprofen, an anti-inflammatory analgesic. In addition, the company offers colesevelam for treating hypercholesterolemia and type 2 diabetes mellitus treatment; and ferric carboxymaltose and iron sucrose injections for treating anemia. Further, it provides Lulu, a combination cold remedy; Loxonin S, an antipyretic analgesic /anti-inflammatory analgesic; Transino for melasma improvement and treating against spots and freckles; Minon, a skincare product; and Breath Labo and Clean Dental oral care products, as well as Silodosin for dysuria; Gefitinib for malignant tumours; Bicalutamide for prostate cancer; and Tamoxifen, an anti-breast cancer agent. Additionally, the company offers adsorbed cell culture-derived influenza, influenza HA, measles rubella combined, and mumps vaccines. It also provides pharmaceuticals and drugs for animals, cosmetics, medical equipment, food products, drinking water, active pharmaceutical ingredients, and intermediates. It has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer. The company was founded in 1899 and is headquartered in Tokyo, Japan.

Sector

Healthcare

Industry

Drug Manufacturers—General

Country

Japan

Exchange

JPX

Earnings Per Share

39.11

P/E Ratio

102.32677

Debt/Equity Ratio

11.667

Beta

-

City

Tokyo

Address

3-5-1, Nihonbashi-honcho

Zip

103-8426

Ebitda

120,070,995,968.00

-

Enterprise to Ebitda

52.12

Enterprise Value

6,258,373,951,488.00

Target Price

4,180.80

Estimated Price

-

Book Value

663.85

Expected Growth

-

Balance sheet

Income statement

Sustainability

Correlation

Company Name Correlation
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE -0.39
1093.HK CSPC PHARMA -0.38
HZNP Horizon Therapeutics Public Lim -0.17
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI -0.16
600613.SS SHANGHAI SHENQI PHARM INVEST MA -0.14
ECILC.IS ECZACIBASI ILAC -0.11
2186.HK LUYE PHARMA -0.11
GSK.L GSK PLC -0.07
GSK GSK plc -0.06
BMY Bristol-Myers Squibb Company -0.05
600867.SS TONGHUA DONGBAO MEDICINES CO LT -0.04
600713.SS NANJING PHARMACEUTICAL CO LTD -0.02
600276.SS JIANGSU HENGRUI MEDICAL CO LTD -0.00
JNJ Johnson & Johnson -0.00
4503.T ASTELLAS PHARMA -0.00
LLY Eli Lilly and Company 0.06
PFE Pfizer, Inc. 0.07
SNY Sanofi 0.07
AZN Astrazeneca PLC 0.09
300006.SZ CHONGQING LUMMY PH 0.09
MRK Merck & Company, Inc. 0.11
AMGN Amgen Inc. 0.12
MYX.AX M PHARMA FPO 0.16
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C 0.16
ABBV AbbVie Inc. 0.22
4519.T CHUGAI PHARMACEUTICAL CO 0.24
NOVN.SW NOVARTIS N 0.31
GILD Gilead Sciences, Inc. 0.34
KLBF.JK Kalbe Farma Tbk. 0.45

Similar companies

Ticker Name City Country Currency Exchange Beta EV/EBITDA Employees Site
600276.SS JIANGSU HENGRUI MEDICAL CO LTD Lianyungang China CNY SHH 58.730 24491 https://www.hrs.com.cn
KLBF.JK Kalbe Farma Tbk. Jakarta Indonesia IDR JKT 0.500 14.499 12392 https://www.kalbe.co.id
1093.HK CSPC PHARMA Shijiazhuang China HKD HKG 0.669 12.860 24746 https://www.cspc.com.hk
300006.SZ CHONGQING LUMMY PH Chongqing China CNY SHZ 0.826 -32.334 935 https://www.cqlummy.com
PFE Pfizer, Inc. New York United States USD NYQ 0.679 6.878 79000 https://www.pfizer.com
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C Hangzhou China CNY SHH 0.458 10.685 8589 https://www.conbagroup.com
600713.SS NANJING PHARMACEUTICAL CO LTD Nanjing China CNY SHH 0.458 9.366 5062 https://www.njyy.com
600867.SS TONGHUA DONGBAO MEDICINES CO LT Tonghua China CNY SHH 0.237 12.421 https://www.thdb.com
ECILC.IS ECZACIBASI ILAC Istanbul Turkey TRY IST 0.202 71.703 336 https://www.eczacibasi.com.tr/en/eczacibasi-gruop/companies/other-products-and-services
GSK.L GSK PLC Brentford United Kingdom GBp LSE 0.323 6.217 90096 https://www.gsk.com
MRK Merck & Company, Inc. Kenilworth United States USD NYQ 0.355 10.372 67000 https://www.merck.com
BMY Bristol-Myers Squibb Company New York United States USD NYQ 0.442 8.866 32200 https://www.bms.com
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI Xi'an China CNY SHH 0.546 -48.110 1900 https://www.guangyuyuan.com
GILD Gilead Sciences, Inc. Foster City United States USD NMS 0.391 7.192 14400 https://www.gilead.com
JNJ Johnson & Johnson New Brunswick United States USD NYQ 0.568 14.446 141700 https://www.jnj.com
GSK GSK plc Brentford United Kingdom USD NYQ 0.184 8.076 90096 https://www.gsk.com
AZN Astrazeneca PLC Cambridge United Kingdom USD NMS 0.119 18.553 83100 https://www.astrazeneca.com
ABBV AbbVie Inc. North Chicago United States USD NYQ 0.749 11.461 50000 https://www.abbvie.com
2186.HK LUYE PHARMA Yantai China HKD HKG 0.747 14.061 4845 https://www.luye.cn
600613.SS SHANGHAI SHENQI PHARM INVEST MA Shanghai China CNY SHH 0.359 22.962 1371 https://www.gzsq.com
MYX.AX M PHARMA FPO Salisbury South Australia AUD ASX 1.088 27.982 https://www.maynepharma.com
4568.T DAIICHI SANKYO COMPANY LIMITED Tokyo Japan JPY JPX 52.122 16458 https://www.daiichisankyo.com
4503.T ASTELLAS PHARMA Tokyo Japan JPY JPX 0.582 12.390 14522 https://www.astellas.com
NOVN.SW NOVARTIS N Basel Switzerland CHF EBS 0.498 10.304 108000 https://www.novartis.com
SNY Sanofi Paris France USD NMS 0.363 9.753 95442 https://www.sanofi.com
HZNP Horizon Therapeutics Public Lim Dublin Ireland USD NMS 1.157 20.666 1940 https://www.horizontherapeutics.com
LLY Eli Lilly and Company Indianapolis United States USD NYQ 0.367 28.997 35000 https://www.lilly.com
AMGN Amgen Inc. Thousand Oaks United States USD NMS 0.582 12.605 24200 https://www.amgen.com
4519.T CHUGAI PHARMACEUTICAL CO Tokyo Japan JPY JPX 0.635 9.600 7664 https://www.chugai-pharm.co.jp
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE Zhangzhou China CNY SHH 0.777 57.527 2591 https://www.zzpzh.com.cn
BAYN.DE BAYER AG Leverkusen Germany EUR GER 1.160 13.665 101914 https://www.bayer.com
AZN.L ASTRAZENECA PLC ORD SHS $0.25 Cambridge United Kingdom GBp LSE 0.097 15.964 83100 https://www.astrazeneca.com
300357.SZ ZHEJIANG WOLWO BIO Huzhou China CNY SHZ 0.403 56.571 1488 https://www.wolwobiotech.com
SAN.PA SANOFI Paris France EUR PAR 0.356 9.863 95442 https://www.sanofi.com
NVS Novartis AG Basel Switzerland USD NYQ 0.488 10.621 108000 https://www.novartis.com
0P6S.IL BAYER AG Leverkusen Germany EUR IOB 1.148 9.508 100753 https://www.bayer.com
CIPLA.NS CIPLA LTD Mumbai India INR NSI 17.912 https://www.cipla.com
4528.T ONO PHARMACEUTICAL CO Osaka Japan JPY JPX 0.332 13.404 3687 https://www.ono-pharma.com
4536.T SANTEN PHARMACEUTICAL CO Osaka Japan JPY JPX 0.375 7.050 4315 https://www.santen.com
OGN Organon & Co. Jersey City United States USD NYQ 7.831 9300 https://www.organon.com

Funds


Mutual Fund Holders

Social

Dividends

Ratings

News

Earnings

SEC Filings

Options

Indicators

Glossary
Momentum
A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
Inertia
In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
Relative Strength Index (RSI)
A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
Fibonacci's Weighted Moving Average
A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
Williams %R
A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
Relative Volatility Index (RVI)
A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
Commodity Channel Index (CCI)
A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.